This site is intended for Healthcare professionals only.

Dr Reddy’s Lab launches Omeprazole in the US market

Dr Reddy’s Lab launches Omeprazole in the US market

New Delhi: Dr Reddy’s Laboratories recently said it has launched Omeprazole delayed-release tablets, used to treat frequent heartburn, in the US market.

“Dr Reddy’s Laboratories has launched Omeprazole delayed-release tablets in the strength of 20 mg, an over-the-counter (OTC) store-brand equivalent of Prilosec tablets, in the US,” the company said in a BSE filing.

Quoting IRI data, Dr Reddy’s Laboratories said the combined market of Prilosec OTC and private label omeprazole OTC products had US retail sales of around USD 492 million for the most recent twelve months ending in October 2018.

Read Also: Dr Reddy’s Laboratories recalls 35,000 tubes of skin infection cream from US

The following two tabs change content below.
MD Team

MD Team

At Medical Dialogues, we are a team of young professionals strongly advocating of the transparency in the medical sector through the free flow of medical information, health and medical news. MD Team covers a variety of news related to the healthcare, pharma and medical device industry in India. Our team can be contacted at Contact no. 011-43720751

Source: PTI
0 comment(s) on Dr Reddy’s Lab launches Omeprazole in the US market

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted